Zydus Wellness share price has remained volatile amid fluctuating market. In last one year, the stock has gained over 4.16 per cent, however, has lost 3.59 per cent in six months ...

Zydus Wellness shares rallied 7 per cent on Wednesday, after True North exited by divesting its entire 7.27 per cent stake ...

View the latest Zydus Lifesciences Ltd. (532321) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Zydus Lifesciences Ltd announced the closure of a USFDA follow-up inspection at its oncology injectable site near Matoda, ...

Zydus Lifesciences announced that a recent FDA audit at its Ahmedabad oncology unit concluded with only two minor ...

As Indian cities battled sweltering heatwaves this summer, Zydus Wellness' Glucon-D, India's most trusted glucose-based ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus Lifesciences Ltd. (NSE: ZYDUSLIFE), including its ...

Around 46.27 lakh shares of Zydus Wellness, equaling around 7.3 percent of the total equity in the firm, changed hands at Rs 1,900 per share.

The acquisition will establish Zydus' presence in fast growing global biologics CDMO space. Acquired capabilities include cutting-edge biologics development and manufacturing services to serve the ...

Under the deal, Zydus will purchase certain Agenus facilities in Emeryville, Calif., and Berkeley, Calif., for $75 million. India-based Zydus will use these facilities as their flagship U.S. sites ...

As per the IQVIA data (March, 2025), the Rifaximin tablets had annual sales of $2,672.9 million in the US market.